These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Serum levels of vascular endothelial growth factor and basic fibroblastic growth factor in children with hemangiomas and vascular malformations--preliminary report. Przewratil P; Sitkiewicz A; Wyka K; Andrzejewska E Pediatr Dermatol; 2009; 26(4):399-404. PubMed ID: 19689513 [TBL] [Abstract][Full Text] [Related]
43. Multifocal rapidly involuting congenital hemangioma: a link to chorangioma. Mulliken JB; Bischoff J; Kozakewich HP Am J Med Genet A; 2007 Dec; 143A(24):3038-46. PubMed ID: 17937433 [TBL] [Abstract][Full Text] [Related]
44. Decreased eNOS protein expression in involuting and propranolol-treated hemangiomas. Dai Y; Hou F; Buckmiller L; Fan CY; Saad A; Suen J; Richter GT Arch Otolaryngol Head Neck Surg; 2012 Feb; 138(2):177-82. PubMed ID: 22351865 [TBL] [Abstract][Full Text] [Related]
45. Beta blocker treatment of infantile conjunctival hemangiomas--observations from 2 cases. Chang TC; Estes R J AAPOS; 2014 Feb; 18(1):80-2. PubMed ID: 24568991 [TBL] [Abstract][Full Text] [Related]
46. The adipogenesis in infantile hemangioma and the expression of adipogenic-related genes. Yuan SM; Guo Y; Xu Y; Wang M; Chen HN; Shen WM Int J Clin Exp Pathol; 2017; 10(12):11596-11602. PubMed ID: 31966516 [TBL] [Abstract][Full Text] [Related]
53. Propranolol represses infantile hemangioma cell growth through the β2-adrenergic receptor in a HIF-1α-dependent manner. Li P; Guo Z; Gao Y; Pan W Oncol Rep; 2015 Jun; 33(6):3099-107. PubMed ID: 25872592 [TBL] [Abstract][Full Text] [Related]
54. Simple and easy surgical technique for infantile hemangiomas: intralesional excision and primary closure. Nomura T; Osaki T; Ishinagi H; Ejiri H; Terashi H Eplasty; 2015; 15():e3. PubMed ID: 25610518 [TBL] [Abstract][Full Text] [Related]
55. Hypoxia-Induced Cyr61/CCN1 Production in Infantile Hemangioma. Wu P; Xu H; Li N; Huo R; Shen B; Lin X; Ma G Plast Reconstr Surg; 2021 Mar; 147(3):412e-423e. PubMed ID: 33587560 [TBL] [Abstract][Full Text] [Related]
56. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. Takahashi K; Mulliken JB; Kozakewich HP; Rogers RA; Folkman J; Ezekowitz RA J Clin Invest; 1994 Jun; 93(6):2357-64. PubMed ID: 7911127 [TBL] [Abstract][Full Text] [Related]
57. M1 Macrophage-Induced Endothelial-to-Mesenchymal Transition Promotes Infantile Hemangioma Regression. Wu KQ; Muratore CS; So EY; Sun C; Dubielecka PM; Reginato AM; Liang OD Am J Pathol; 2017 Sep; 187(9):2102-2111. PubMed ID: 28710904 [TBL] [Abstract][Full Text] [Related]
58. [Role of urinary basic fibroblast growth factor in differentiating hemangiomas from vascular malformation]. Zhang L; Lin XX; Qi ZL; Dong JS; Zou LJ; Dai CC; Li W; Wang W Zhonghua Wai Ke Za Zhi; 2006 Feb; 44(3):186-8. PubMed ID: 16635349 [TBL] [Abstract][Full Text] [Related]
59. The presentation and management of hemangiomas. Beck DO; Gosain AK Plast Reconstr Surg; 2009 Jun; 123(6):181e-191e. PubMed ID: 19483535 [TBL] [Abstract][Full Text] [Related]